AZD8601 study in CABG patients

Trial Identifier:	D9150C00003
Sponsor:	AstraZeneca
NCTID::	NCT03370887
Start Date:	February 2018
Primary Completion Date:	June 2021
Study Completion Date:	June 2021
Condition:	Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Finnish Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
DE	München, DE, 80363
DE	München, DE, 81675
FI	Kuopio, FI, 70210
FI	Tampere, FI, 33520
FI	Turku, FI, 20520
NL	Groningen, NL, 9713 GZ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.